Testing the Model for Predicting Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis.

Testing the Model for Predicting Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis.
J Rheumatol. 2019 Jun 15;:
Authors: Ozen S, Demir S, Batu ED
Abstract
We read the article by Saccomanno, et al, "Predictors of effectiveness of anakinra in systemic juvenile idiopathic arthritis," with great interest1 They reported that shorter disease duration, fewer active joints, higher ferritin levels, and greater activity of systemic manifestations were independently correlated with achievement of complete clinical response at 1 year (CCR1) in systemic juvenile idiopathic arthritis (sJIA).
PMID: 31203219 [PubMed - as supplied by publisher]

Source: J Rheumatol - June 14, 2019 Category: Rheumatology Authors: Ozen S, Demir S, Batu ED Tags: J Rheumatol Source Type: research